You have 9 free searches left this month | for more free features.

Condition

Colorectal Cancer (2)

Biliary Carcinoma (1)

Ovarian Cancer (1)

Pancreatic Adenocarcinoma (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Hoffmann-La Roche (1)

Lokon Pharma AB (1)

Collaborator

Uppsala University (1)

Intervention

load703 (2)

ab928 (1)

atezolizumab (1)

bevacizumab (1)

idasanutlin (1)

imprime pgg (1)

isatuximab (1)

regorafenib (1)

selicrelumab (1)

Study Documents

Intervention Type

drug (2)

genetic (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

load703

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pancreatic Adenocarcinoma, Ovarian Cancer, Biliary Carcinoma Trial in Stockholm, Uppsala (LOAd703)

Recruiting

Pancreatic Adenocarcinoma
+3 more

LOAd703

Stockholm, Sweden
+1 more

Apr 4, 2022

Colorectal Cancer Trial in Worldwide (Regorafenib, Atezolizumab, Imprime PGG)

Recruiting

Colorectal Cancer

Regorafenib
+8 more

Duarte, California
+17 more

Aug 3, 2022